Answers are grounded in this paper and cite their sources.
A combination of five simple and commonly available clinical and laboratory variables measured at the time of CDI diagnosis, combined into a scoring system (ATLAS), are able to accurately predict treatment response to CDI therapy. The ATLAS scoring system may be useful in stratifying CDI patients so that appropriate therapies can be chosen to maximize cure rates, as well as for categorization of patients in CDI therapeutic studies in order allow comparisons of patient groups.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: